Adult 0 5 0 5 O
males 6 11 6 11 B-gender

Presence 0 8 12 20 O
of 9 11 21 23 O
neutralising 12 24 24 36 O
anti 25 29 37 41 B-treatment
- 29 30 41 42 I-treatment
hFVIII 30 36 42 48 I-treatment
antibodies 37 47 49 59 I-treatment
( 48 49 60 61 O
inhibitor 49 58 61 70 O
, 58 59 70 71 O
determined 60 70 72 82 O
by 71 73 83 85 O
the 74 77 86 89 O
Bethesda 78 86 90 98 B-clinical_variable
inhibitor 87 96 99 108 I-clinical_variable
assay 97 102 109 114 I-clinical_variable
) 102 103 114 115 O
at 104 106 116 118 O
the 107 110 119 122 O
time 111 115 123 127 O
of 116 118 128 130 O
enrolment 119 128 131 140 O
or 129 131 141 143 O
a 132 133 144 145 O
previous 134 142 146 154 O
history 143 150 155 162 O
of 151 153 163 165 O
hFVIII 154 160 166 172 B-treatment
inhibitor 161 170 173 182 I-treatment

Received 0 8 183 191 O
an 9 11 192 194 O
AAV 12 15 195 198 B-treatment
vector 16 22 199 205 I-treatment
, 22 23 205 206 O
or 24 26 207 209 O
any 27 30 210 213 O
other 31 36 214 219 O
gene 37 41 220 224 O
transfer 42 50 225 233 O
agent 51 56 234 239 O
in 57 59 240 242 O
the 60 63 243 246 O
previous 64 72 247 255 B-upper_bound
6 73 74 256 257 I-upper_bound
months 75 81 258 264 I-upper_bound

Received 0 8 265 273 O
treatment 9 18 274 283 O
with 19 23 284 288 O
human 24 29 289 294 B-clinical_variable
FVIII 30 35 295 300 I-clinical_variable
concentrates 36 48 301 313 O
with 49 53 314 318 O
at 54 56 319 321 O
least 57 62 322 327 O
> 63 64 328 329 O
50 64 66 329 331 B-lower_bound
exposure 67 75 332 340 I-lower_bound
days 76 80 341 345 I-lower_bound

Serological 0 11 346 357 O
evidence 12 20 358 366 O
of 21 23 367 369 O
HIV-1 24 29 370 375 B-chronic_disease
who 30 33 376 379 O
have 34 38 380 384 O
CD4 39 42 385 388 B-clinical_variable
counts 43 49 389 395 I-clinical_variable
≤ 50 51 396 397 O
200 52 55 398 401 B-upper_bound
/ 55 56 401 402 I-upper_bound
mm3 56 59 402 405 I-upper_bound

Severe 0 6 406 412 B-chronic_disease
haemophilia 7 18 413 424 I-chronic_disease
A 19 20 425 426 I-chronic_disease
patients 21 29 427 435 O
with 30 34 436 440 O
large 35 40 441 446 O
deletions 41 50 447 456 O
( 51 52 457 458 O
multiple 52 60 458 466 O
exons 61 66 467 472 O
) 66 67 472 473 O
and 68 71 474 477 O
nonsense 72 80 478 486 O
mutations 81 90 487 496 O
of 91 93 497 499 O
the 94 97 500 503 O
F8 98 100 504 506 O
gene 101 105 507 511 O

Suspicious 0 10 512 522 O
Lung 11 15 523 527 B-cancer
lesions 16 23 528 535 I-cancer
on 24 26 536 538 O
CT 27 29 539 541 O
scan 30 34 542 546 O
that 35 39 547 551 O
raise 40 45 552 557 O
the 46 49 558 561 O
possibility 50 61 562 573 O
of 62 64 574 576 O
cancer 65 71 577 583 B-cancer
or 72 74 584 586 O
premalignant 75 87 587 599 B-cancer
pathology 88 97 600 609 I-cancer

Uncontrolled 0 12 610 622 O
glaucoma 13 21 623 631 B-chronic_disease
, 21 22 631 632 O
diabetes 23 31 633 641 B-chronic_disease
mellitus 32 40 642 650 I-chronic_disease
, 40 41 650 651 O
or 42 44 652 654 O
hypertension 45 57 655 667 B-chronic_disease
( 58 59 668 669 O
systolic 59 67 669 677 B-clinical_variable
BP 68 70 678 680 I-clinical_variable
consistently 71 83 681 693 O
≥140 84 88 694 698 O
mmHg 89 93 699 703 I-lower_bound
or 94 96 704 706 O
diastolic 97 106 707 716 B-clinical_variable
BP 107 109 717 719 I-clinical_variable
consistently 110 122 720 732 O
≥90 123 126 733 736 O
mmHg 127 131 737 741 I-lower_bound
) 131 132 741 742 O

Use 0 3 743 746 O
of 4 6 747 749 O
investigational 7 22 750 765 B-treatment
therapy 23 30 766 773 I-treatment
for 31 34 774 777 O
haemophilia 35 46 778 789 B-chronic_disease
within 47 53 790 796 O
30 54 56 797 799 B-upper_bound
days 57 61 800 804 I-upper_bound
before 62 68 805 811 O
enrolment 69 78 812 821 O

active 0 6 822 828 B-chronic_disease
hepatitis 7 16 829 838 I-chronic_disease
B 17 18 839 840 I-chronic_disease
or 19 21 841 843 I-chronic_disease
C 22 23 844 845 I-chronic_disease
, 23 24 845 846 O
and 25 28 847 850 O
HBsAg 29 34 851 856 B-chronic_disease
or 35 37 857 859 O
HCV 38 41 860 863 B-chronic_disease
RNA 42 45 864 867 O
viral 46 51 868 873 O
load 52 56 874 878 O
positivity 57 67 879 889 O
, 67 68 889 890 O
respectively 69 81 891 903 O
or 82 84 904 906 O
currently 85 94 907 916 O
on 95 97 917 919 O
antiviral 98 107 920 929 B-treatment
therapy 108 115 930 937 I-treatment
for 116 119 938 941 O
hepatitis 120 129 942 951 O
B 130 131 952 953 O
or 132 134 954 956 O
C 135 136 957 958 O

active 0 6 959 965 B-chronic_disease
tuberculosis 7 19 966 978 I-chronic_disease

aged 0 4 979 983 B-age
18 5 7 984 986 B-lower_bound
years 8 13 987 992 I-lower_bound
or 14 16 993 995 O
over 17 21 996 1000 O

confirmed 0 9 1001 1010 O
diagnosis 10 19 1011 1020 O
of 20 22 1021 1023 O
severe 23 29 1024 1030 O
Haemophilia 30 41 1031 1042 B-chronic_disease
A 42 43 1043 1044 I-chronic_disease
defined 44 51 1045 1052 O
as 52 54 1053 1055 O
baseline 55 63 1056 1064 O
plasma 64 70 1065 1071 B-clinical_variable
FVIII 71 76 1072 1077 I-clinical_variable
levels 77 83 1078 1084 I-clinical_variable
of 84 86 1085 1087 O
< 87 88 1088 1089 O
1 88 89 1089 1090 B-upper_bound
% 89 90 1090 1091 I-upper_bound
of 91 93 1092 1094 O
normal 94 100 1095 1101 O
as 101 103 1102 1104 O
assessed 104 112 1105 1113 O
by 113 115 1114 1116 O
a 116 117 1117 1118 O
validated 118 127 1119 1128 O
one 128 131 1129 1132 O
- 131 132 1132 1133 O
stage 132 137 1133 1138 O
clotting 138 146 1139 1147 O
assay 147 152 1148 1153 O
or 153 155 1154 1156 O
a 156 157 1157 1158 O
chromogenic 158 169 1159 1170 O
assay 170 175 1171 1176 O
, 175 176 1176 1177 O
resulting 177 186 1178 1187 O
from 187 191 1188 1192 O
intron 192 198 1193 1199 O
22 199 201 1200 1202 O
inversions 202 212 1203 1213 O
, 212 213 1213 1214 O
intron 214 220 1215 1221 O
1 221 222 1222 1223 O
inversions 223 233 1224 1234 O
, 233 234 1234 1235 O
splice 235 241 1236 1242 O
- 241 242 1242 1243 O
site 242 246 1243 1247 O
mutations 247 256 1248 1257 O
, 256 257 1257 1258 O
small 258 263 1259 1264 O
deletions 264 273 1265 1274 O
/ 273 274 1274 1275 O
insertions 274 284 1275 1285 O
and 285 288 1286 1289 O
missense 289 297 1290 1298 O
mutations 298 307 1299 1308 O

liver 0 5 1309 1314 B-chronic_disease
dysfunction 6 17 1315 1326 I-chronic_disease
( 18 19 1327 1328 O
persistently 19 31 1328 1340 O
elevated 32 40 1341 1349 O
ALT 41 44 1350 1353 B-clinical_variable
> 45 46 1354 1355 O
1.5X 46 50 1355 1359 B-lower_bound
upper 51 56 1360 1365 I-lower_bound
limit 57 62 1366 1371 I-lower_bound
of 63 65 1372 1374 I-lower_bound
normal 66 72 1375 1381 I-lower_bound
) 72 73 1381 1382 O

malignancy 0 10 1383 1393 B-cancer

other 0 5 1394 1399 O
chronic 6 13 1400 1407 B-chronic_disease
infection 14 23 1408 1417 I-chronic_disease

severe 0 6 1418 1424 O
bleeding 7 15 1425 1433 B-chronic_disease
phenotype 16 25 1434 1443 I-chronic_disease

